Asia-Pacific Orphan Drugs Market Report 2017

December 2017 | 113 pages | ID: A8F43E9B733EN
QYResearch

Abstracts

In this report, the Asia-Pacific Orphan Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Orphan Drugs for these regions, from 2012 to 2022 (forecast), including

• China
• Japan
• South Korea
• Taiwan
• India
• Southeast Asia
• Australia

Asia-Pacific Orphan Drugs market competition by top manufacturers/players, with Orphan Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis AG
• Bristol-Myers Squibb Company
• Celgene Corporation
• F. Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• Sanofi S.A.
• Alexion Pharmaceuticals, Inc.
• Eli Lilly and Company
• Novo Nordisk A/S
• AstraZeneca
• Eisai Co., Ltd.
• Daiichi Sankyo Company Limited
• Bayer AG
• GlaxoSmithKline
• Merck & Co., Inc.
• Johnson & Johnson
• Biogen, Inc.
• Shire
• Amgen, Inc.

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Oncology
• Gastrointestinal
• Pulmonary
• Neurology
• Hematology
• Cardio-vascular
• Metabolic disorders
• Endocrinology
• Infectious diseases
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Orphan Drugs for each application, includin

• Hospital Pharmacies
• Speciality Pharmacies
• Retail pharmacies
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Asia-Pacific Orphan Drugs Market Report 2017

1 ORPHAN DRUGS OVERVIEW

1.1 Product Overview and Scope of Orphan Drugs
1.2 Classification of Orphan Drugs by Product Category
  1.2.1 Asia-Pacific Orphan Drugs Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Orphan Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Oncology
  1.2.4 Gastrointestinal
  1.2.5 Pulmonary
  1.2.6 Neurology
  1.2.7 Hematology
  1.2.8 Cardio-vascular
  1.2.9 Metabolic disorders
  1.2.10 Endocrinology
  1.2.11 Infectious diseases
  1.2.12 Others
1.3 Asia-Pacific Orphan Drugs Market by Application/End Users
  1.3.1 Asia-Pacific Orphan Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Hospital Pharmacies
  1.3.3 Speciality Pharmacies
  1.3.4 Retail pharmacies
  1.3.5 Others
1.4 Asia-Pacific Orphan Drugs Market by Region
  1.4.1 Asia-Pacific Orphan Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Orphan Drugs (2012-2022)
  1.5.1 Asia-Pacific Orphan Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Orphan Drugs Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC ORPHAN DRUGS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Orphan Drugs Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Orphan Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Orphan Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Orphan Drugs (Volume and Value) by Type
  2.2.1 Asia-Pacific Orphan Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Orphan Drugs Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Orphan Drugs (Volume) by Application
2.4 Asia-Pacific Orphan Drugs (Volume and Value) by Region
  2.4.1 Asia-Pacific Orphan Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Orphan Drugs Revenue and Market Share by Region (2012-2017)

3 CHINA ORPHAN DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 China Orphan Drugs Sales and Value (2012-2017)
  3.1.1 China Orphan Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Orphan Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 China Orphan Drugs Sales Price Trend (2012-2017)
3.2 China Orphan Drugs Sales Volume and Market Share by Type
3.3 China Orphan Drugs Sales Volume and Market Share by Application

4 JAPAN ORPHAN DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Orphan Drugs Sales and Value (2012-2017)
  4.1.1 Japan Orphan Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Orphan Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Orphan Drugs Sales Price Trend (2012-2017)
4.2 Japan Orphan Drugs Sales Volume and Market Share by Type
4.3 Japan Orphan Drugs Sales Volume and Market Share by Application

5 SOUTH KOREA ORPHAN DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Orphan Drugs Sales and Value (2012-2017)
  5.1.1 South Korea Orphan Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Orphan Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Orphan Drugs Sales Price Trend (2012-2017)
5.2 South Korea Orphan Drugs Sales Volume and Market Share by Type
5.3 South Korea Orphan Drugs Sales Volume and Market Share by Application

6 TAIWAN ORPHAN DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Orphan Drugs Sales and Value (2012-2017)
  6.1.1 Taiwan Orphan Drugs Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Orphan Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Orphan Drugs Sales Price Trend (2012-2017)
6.2 Taiwan Orphan Drugs Sales Volume and Market Share by Type
6.3 Taiwan Orphan Drugs Sales Volume and Market Share by Application

7 INDIA ORPHAN DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 India Orphan Drugs Sales and Value (2012-2017)
  7.1.1 India Orphan Drugs Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Orphan Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 India Orphan Drugs Sales Price Trend (2012-2017)
7.2 India Orphan Drugs Sales Volume and Market Share by Type
7.3 India Orphan Drugs Sales Volume and Market Share by Application

8 SOUTHEAST ASIA ORPHAN DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Orphan Drugs Sales and Value (2012-2017)
  8.1.1 Southeast Asia Orphan Drugs Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Orphan Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Orphan Drugs Sales Price Trend (2012-2017)
8.2 Southeast Asia Orphan Drugs Sales Volume and Market Share by Type
8.3 Southeast Asia Orphan Drugs Sales Volume and Market Share by Application

9 AUSTRALIA ORPHAN DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Orphan Drugs Sales and Value (2012-2017)
  9.1.1 Australia Orphan Drugs Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Orphan Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Orphan Drugs Sales Price Trend (2012-2017)
9.2 Australia Orphan Drugs Sales Volume and Market Share by Type
9.3 Australia Orphan Drugs Sales Volume and Market Share by Application

10 ASIA-PACIFIC ORPHAN DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Novartis AG
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Orphan Drugs Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Novartis AG Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Bristol-Myers Squibb Company
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Orphan Drugs Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Bristol-Myers Squibb Company Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Celgene Corporation
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Orphan Drugs Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Celgene Corporation Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 F. Hoffmann-La Roche Ltd.
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Orphan Drugs Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 F. Hoffmann-La Roche Ltd. Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Pfizer, Inc.
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Orphan Drugs Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Pfizer, Inc. Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Sanofi S.A.
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Orphan Drugs Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Sanofi S.A. Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Alexion Pharmaceuticals, Inc.
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Orphan Drugs Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Alexion Pharmaceuticals, Inc. Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Eli Lilly and Company
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Orphan Drugs Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Eli Lilly and Company Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Novo Nordisk A/S
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Orphan Drugs Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Novo Nordisk A/S Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 AstraZeneca
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Orphan Drugs Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 AstraZeneca Orphan Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Eisai Co., Ltd.
10.12 Daiichi Sankyo Company Limited
10.13 Bayer AG
10.14 GlaxoSmithKline
10.15 Merck & Co., Inc.
10.16 Johnson & Johnson
10.17 Biogen, Inc.
10.18 Shire
10.19 Amgen, Inc.

11 ORPHAN DRUGS MANUFACTURING COST ANALYSIS

11.1 Orphan Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Orphan Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Orphan Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Orphan Drugs Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC ORPHAN DRUGS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Orphan Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Orphan Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Orphan Drugs Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Orphan Drugs Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Orphan Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Orphan Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Orphan Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Orphan Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Orphan Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Orphan Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Orphan Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Orphan Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Orphan Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Orphan Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Orphan Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Orphan Drugs Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Orphan Drugs Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Orphan Drugs Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Orphan Drugs Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Orphan Drugs
Figure Asia-Pacific Orphan Drugs Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Orphan Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Oncology Product Picture
Figure Gastrointestinal Product Picture
Figure Pulmonary Product Picture
Figure Neurology Product Picture
Figure Hematology Product Picture
Figure Cardio-vascular Product Picture
Figure Metabolic disorders Product Picture
Figure Endocrinology Product Picture
Figure Infectious diseases Product Picture
Figure Others Product Picture
Figure Asia-Pacific Orphan Drugs Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Orphan Drugs by Application in 2016
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Speciality Pharmacies Examples
Table Key Downstream Customer in Speciality Pharmacies
Figure Retail pharmacies Examples
Table Key Downstream Customer in Retail pharmacies
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Orphan Drugs Market Size (Million USD) by Region (2012-2022)
Figure China Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Orphan Drugs Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Orphan Drugs Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Orphan Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Orphan Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Orphan Drugs Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Orphan Drugs Sales Share by Players/Suppliers
Figure Asia-Pacific Orphan Drugs Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Orphan Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Orphan Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Orphan Drugs Revenue Share by Players
Figure 2017 Asia-Pacific Orphan Drugs Revenue Share by Players
Table Asia-Pacific Orphan Drugs Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Orphan Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Orphan Drugs by Type (2012-2017)
Figure Asia-Pacific Orphan Drugs Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Orphan Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Orphan Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Orphan Drugs by Type (2012-2017)
Figure Asia-Pacific Orphan Drugs Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Orphan Drugs Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Orphan Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Orphan Drugs by Region (2012-2017)
Figure Asia-Pacific Orphan Drugs Sales Market Share by Region in 2016
Table Asia-Pacific Orphan Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Orphan Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Orphan Drugs by Region (2012-2017)
Figure Asia-Pacific Orphan Drugs Revenue Market Share by Region in 2016
Table Asia-Pacific Orphan Drugs Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Orphan Drugs Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Orphan Drugs Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Orphan Drugs Sales Market Share by Application (2012-2017)
Figure China Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure China Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Orphan Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table China Orphan Drugs Sales Volume (K Units) by Type (2012-2017)
Table China Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Orphan Drugs Sales Volume Market Share by Type in 2016
Table China Orphan Drugs Sales Volume (K Units) by Applications (2012-2017)
Table China Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Orphan Drugs Sales Volume Market Share by Application in 2016
Figure Japan Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Orphan Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Orphan Drugs Sales Volume (K Units) by Type (2012-2017)
Table Japan Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Orphan Drugs Sales Volume Market Share by Type in 2016
Table Japan Orphan Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Japan Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Orphan Drugs Sales Volume Market Share by Application in 2016
Figure South Korea Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Orphan Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Orphan Drugs Sales Volume (K Units) by Type (2012-2017)
Table South Korea Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure South Korea Orphan Drugs Sales Volume Market Share by Type in 2016
Table South Korea Orphan Drugs Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure South Korea Orphan Drugs Sales Volume Market Share by Application in 2016
Figure Taiwan Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Orphan Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Orphan Drugs Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Orphan Drugs Sales Volume Market Share by Type in 2016
Table Taiwan Orphan Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Orphan Drugs Sales Volume Market Share by Application in 2016
Figure India Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure India Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Orphan Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table India Orphan Drugs Sales Volume (K Units) by Type (2012-2017)
Table India Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Orphan Drugs Sales Volume Market Share by Type in 2016
Table India Orphan Drugs Sales Volume (K Units) by Application (2012-2017)
Table India Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Orphan Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Orphan Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Orphan Drugs Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Orphan Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Orphan Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Orphan Drugs Sales Volume Market Share by Application in 2016
Figure Australia Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Orphan Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Orphan Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Orphan Drugs Sales Volume (K Units) by Type (2012-2017)
Table Australia Orphan Drugs Sales Volume Market Share by Type (2012-2017)
Figure Australia Orphan Drugs Sales Volume Market Share by Type in 2016
Table Australia Orphan Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Australia Orphan Drugs Sales Volume Market Share by Application (2012-2017)
Figure Australia Orphan Drugs Sales Volume Market Share by Application in 2016
Table Novartis AG Orphan Drugs Basic Information List
Table Novartis AG Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis AG Orphan Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis AG Orphan Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Bristol-Myers Squibb Company Orphan Drugs Basic Information List
Table Bristol-Myers Squibb Company Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Orphan Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Bristol-Myers Squibb Company Orphan Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Celgene Corporation Orphan Drugs Basic Information List
Table Celgene Corporation Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celgene Corporation Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Celgene Corporation Orphan Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Celgene Corporation Orphan Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table F. Hoffmann-La Roche Ltd. Orphan Drugs Basic Information List
Table F. Hoffmann-La Roche Ltd. Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Orphan Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Orphan Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer, Inc. Orphan Drugs Basic Information List
Table Pfizer, Inc. Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer, Inc. Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer, Inc. Orphan Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer, Inc. Orphan Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Sanofi S.A. Orphan Drugs Basic Information List
Table Sanofi S.A. Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi S.A. Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi S.A. Orphan Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Sanofi S.A. Orphan Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Alexion Pharmaceuticals, Inc. Orphan Drugs Basic Information List
Table Alexion Pharmaceuticals, Inc. Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alexion Pharmaceuticals, Inc. Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Alexion Pharmaceuticals, Inc. Orphan Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Alexion Pharmaceuticals, Inc. Orphan Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Eli Lilly and Company Orphan Drugs Basic Information List
Table Eli Lilly and Company Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Eli Lilly and Company Orphan Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Eli Lilly and Company Orphan Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Novo Nordisk A/S Orphan Drugs Basic Information List
Table Novo Nordisk A/S Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk A/S Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Novo Nordisk A/S Orphan Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Novo Nordisk A/S Orphan Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table AstraZeneca Orphan Drugs Basic Information List
Table AstraZeneca Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Orphan Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Orphan Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure AstraZeneca Orphan Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Eisai Co., Ltd. Orphan Drugs Basic Information List
Table Daiichi Sankyo Company Limited Orphan Drugs Basic Information List
Table Bayer AG Orphan Drugs Basic Information List
Table GlaxoSmithKline Orphan Drugs Basic Information List
Table Merck & Co., Inc. Orphan Drugs Basic Information List
Table Johnson & Johnson Orphan Drugs Basic Information List
Table Biogen, Inc. Orphan Drugs Basic Information List
Table Shire Orphan Drugs Basic Information List
Table Amgen, Inc. Orphan Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Orphan Drugs
Figure Manufacturing Process Analysis of Orphan Drugs
Figure Orphan Drugs Industrial Chain Analysis
Table Raw Materials Sources of Orphan Drugs Major Manufacturers in 2016
Table Major Buyers of Orphan Drugs
Table Distributors/Traders List
Figure Asia-Pacific Orphan Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Orphan Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Orphan Drugs Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Orphan Drugs Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Orphan Drugs Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Orphan Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Orphan Drugs Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Orphan Drugs Revenue Market Share Forecast by Region in 2022
Figure China Orphan Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Orphan Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Orphan Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Orphan Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Orphan Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Orphan Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Orphan Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Orphan Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Orphan Drugs Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Orphan Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Orphan Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Orphan Drugs Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Orphan Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Orphan Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources